Serge Saxonov - 06 Jul 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role: Chief Executive Officer, Director
Signature: /s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol: TXG
Transactions as of: 06 Jul 2021
Net transactions value: -$2,757,477
Form type: 4
Filing time: 08 Jul 2021, 16:24:35 UTC
Previous filing: 10 Jun 2021
Next filing: 04 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXG	Class A Common Stock	Options Exercise	$26,248	+5,208	+0.58%	$5.04^*	909,276	06 Jul 2021	Direct	F1
transaction	TXG	Class A Common Stock	Options Exercise	$112,412	+9,792	+1.1%	$11.48^*	919,068	06 Jul 2021	Direct	F1
transaction	TXG	Class A Common Stock	Sale	$171,105	-900	-0.1%	$190.12	918,168	06 Jul 2021	Direct	F1, F2
transaction	TXG	Class A Common Stock	Sale	$324,811	-1,700	-0.19%	$191.07	916,468	06 Jul 2021	Direct	F1, F3
transaction	TXG	Class A Common Stock	Sale	$772,061	-4,017	-0.44%	$192.20	912,451	06 Jul 2021	Direct	F1, F4
transaction	TXG	Class A Common Stock	Sale	$585,037	-3,027	-0.33%	$193.27	909,424	06 Jul 2021	Direct	F1, F5
transaction	TXG	Class A Common Stock	Sale	$535,015	-2,756	-0.3%	$194.13	906,668	06 Jul 2021	Direct	F1, F6
transaction	TXG	Class A Common Stock	Sale	$390,247	-2,000	-0.22%	$195.12	904,668	06 Jul 2021	Direct	F1, F7
transaction	TXG	Class A Common Stock	Sale	$98,164	-500	-0.06%	$196.33	904,168	06 Jul 2021	Direct	F1, F8
transaction	TXG	Class A Common Stock	Sale	$19,697	-100	-0.01%	$196.97	904,068	06 Jul 2021	Direct	F1, F9
holding	TXG	Class A Common Stock						89,960	06 Jul 2021	See Footnote	F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TXG	Stock Option (right to buy)	Options Exercise	$0	-5,208	-6.2%	$0.000000	79,365	06 Jul 2021	Class A Common Stock	5,208	$5.04	Direct	F1, F11
transaction	TXG	Stock Option (right to buy)	Options Exercise	$0	-9,792	-11%	$0.000000	77,713	06 Jul 2021	Class A Common Stock	9,792	$11.48	Direct	F1, F12

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
F2	This transaction was executed in multiple trades at prices ranging from $189.54 to $190.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3	This transaction was executed in multiple trades at prices ranging from $190.65 to $191.54. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4	This transaction was executed in multiple trades at prices ranging from $191.66 to $192.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5	This transaction was executed in multiple trades at prices ranging from $192.67 to $193.66. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6	This transaction was executed in multiple trades at prices ranging from $193.67 to $194.66. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7	This transaction was executed in multiple trades at prices ranging from $194.68 to $195.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F8	This transaction was executed in multiple trades at prices ranging from $195.92 to $196.78. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9	This transaction was executed in multiple trades at prices ranging from $196.94 to $196.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F10	The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F11	This option, originally for 250,000 shares, of which 170,635 have been exercised, vested as to one forty-eighth of the shares on October 1, 2018, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F12	This option, originally for 145,786 shares, of which 68,073 have been exercised, vested as to one forty-eighth of the shares on May 1, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.